Transcode Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cogent Biosciences (NASDAQ:COGT – Get Free Report) and TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Analyst Ratings This is a breakdown of […]

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Free Report) – HC Wainwright upped their FY2024 EPS estimates for TransCode Therapeutics in a research report issued on Wednesday, April 3rd. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings of ($2.14) per share for the year, up from their prior estimate of ($25.20). HC […]

Verve Therapeutics (NASDAQ:VERV – Get Free Report) and TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Verve […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and TransCode Therapeutics (NASDAQ:RNAZ – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 15.9% of TransCode Therapeutics shares […]

10.02.2022 - BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be presenting at the 2022 BIO CEO & Investor Conference. TransCode’s Chief Executive Officer, Michael Dudley, will describe the ... Seite 1